Morgan Stanley raised the firm’s price target on Ryan Specialty (RYAN) to $67 from $65 and keeps an Overweight rating on the shares. The firm updated models in the insurance space post the Q3 reports. For property and casualty, Morgan Stanley sees a softening cycle heading into 2026, the analyst tells investors.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RYAN:
- Ryan Specialty price target lowered to $66 from $70 at BMO Capital
- Ryan Specialty price target lowered to $63 from $71 at Goldman Sachs
- Ryan Specialty price target lowered to $65 from $73 at Keefe Bruyette
- Ryan Specialty Group’s Earnings Call: Growth Amid Challenges
- Ryan Specialty Group: Strong Organic Growth and Strategic Investments Justify Buy Rating